Replies to post #1164 on Oramed Pharmaceuticals Inc (ORMP)

[midastouch017]

Oravax Medical gets clearance for Phase 1 oral COVID-19 vaccine trial in South Africa

Oct. 29, 2021 7:42 AM ET Oramed Pharmaceuticals Inc. (ORMP)

By: Aakash Babu, SA News Editor

Oramed Pharmaceuticals (NASDAQ:ORMP) company Oravax Medical has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in the company's early-stage oral COVID-19 vaccine trial.

"An oral COVID-19 vaccine would eliminate several barriers to rapid, widescale distribution, potentially enabling people to administer the vaccine themselves at home," CEO Nadav Kidron said.

"Following this Phase 1 trial, our intention is to move forward with a Phase 2/3 trial for emergency use approval in relevant countries," he added.